#BEGIN_DRUGCARD DB01709

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
24344

# Chemical_Formula:
C3H7O7P

# Chemical_IUPAC_Name:
(2R)-3-hydroxy-2-(phosphonooxy)propanoic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
2-Phosphoglyceric Acid

# HET_ID:
2PG

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C3H7O7P/c4-1-2(3(5)6)10-11(7,8)9/h2,4H,1H2,(H,5,6)(H2,7,8,9)/t2-/m1/s1

# InChI_Key:
InChIKey=GXIURPTVHJPJLF-UWTATZPHSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
1709

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
186.0572

# Molecular_Weight_Mono:
185.99293909

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1PE1

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-2.2

# Predicted_LogS:
-0.96

# Predicted_Water_Solubility:
2.03e+01 g/l

# Primary_Accession_No:
DB01709

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
439278

# PubChem_Substance_ID:
46506872

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT00143

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
OC[C@@H](OP(O)(O)=O)C(O)=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:20:25 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Cytoplasm

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
AE000657

# Drug_Target_1_GenBank_ID_Protein:
2982835

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
kdsA

# Drug_Target_1_Gene_Sequence:
>804 bp
ATGGAAAAGTTTTTAGTGATAGCTGGACCCTGCGCGATAGAGAGCGAGGAACTTCTCCTA
AAGGTAGGGGAGGAGATAAAGCGTTTATCGGAGAAGTTCAAAGAAGTTGAGTTCGTATTT
AAGTCTTCCTTTGATAAAGCGAACCGCTCCTCAATACATTCCTTCAGGGGGCACGGTCTT
GAATACGGGGTAAAGGCTCTGAGGAAGGTAAAGGAAGAGTTCGGACTGAAGATTACCACG
GATATTCACGAGAGCTGGCAAGCTGAACCAGTTGCAGAAGTTGCGGACATAATCCAGATA
CCTGCCTTTTTATGCAGGCAGACTGACCTCCTCCTTGCGGCTGCAAAAACGGGAAGGGCT
GTAAACGTGAAGAAGGGTCAGTTTTTAGCCCCTTGGGACACGAAGAACGTGGTTGAAAAA
TTAAAGTTCGGCGGTGCTAAGGAGATATACCTCACGGAGAGAGGAACTACCTTCGGATAC
AACAACCTCGTTGTAGATTTCAGGAGCCTACCCATAATGAAACAGTGGGCAAAGGTTATA
TACGACGCCACCCACAGCGTCCAGCTCCCCGGAGGTCTCGGGGACAAATCAGGAGGAATG
AGGGAGTTTATATTCCCCTTAATCCGTGCTGCGGTTGCGGTAGGTTGTGACGGTGTGTTT
ATGGAAACACACCCAGAACCAGAAAAGGCACTCTCGGACGCATCAACTCAGCTTCCCCTC
TCCCAGCTGGAAGGGATAATAGAGGCTATCCTTGAGATAAGGGAAGTGGCTTCAAAGTAT
TACGAAACAATTCCCGTTAAATGA

# Drug_Target_1_General_Function:
Cell wall/membrane/envelope biogenesis

# Drug_Target_1_General_References:
10491295	Duewel HS, Sheflyan GY, Woodard RW: Functional and biochemical characterization of a recombinant 3-Deoxy-D-manno-octulosonic acid 8-phosphate synthase from the hyperthermophilic bacterium Aquifex aeolicus. Biochem Biophys Res Commun. 1999 Sep 24;263(2):346-51.
12441100	Wang J, Duewel HS, Stuckey JA, Woodard RW, Gatti DL: Function of His185 in Aquifex aeolicus 3-deoxy-D-manno-octulosonate 8-phosphate synthase. J Mol Biol. 2002 Nov 22;324(2):205-14.
9537320	Deckert G, Warren PV, Gaasterland T, Young WG, Lenox AL, Graham DE, Overbeek R, Snead MA, Keller M, Aujay M, Huber R, Feldman RA, Short JM, Olsen GJ, Swanson RV: The complete genome of the hyperthermophilic bacterium Aquifex aeolicus. Nature. 1998 Mar 26;392(6674):353-8.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2310

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
29735

# Drug_Target_1_Name:
2-dehydro-3-deoxyphosphooctonate aldolase

# Drug_Target_1_Number_of_Residues:
267

# Drug_Target_1_PDB_ID:
1PCW

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00793	DAHP_synth_1

# Drug_Target_1_Protein_Sequence:
>2-dehydro-3-deoxyphosphooctonate aldolase
MEKFLVIAGPCAIESEELLLKVGEEIKRLSEKFKEVEFVFKSSFDKANRSSIHSFRGHGL
EYGVKALRKVKEEFGLKITTDIHESWQAEPVAEVADIIQIPAFLCRQTDLLLAAAKTGRA
VNVKKGQFLAPWDTKNVVEKLKFGGAKEIYLTERGTTFGYNNLVVDFRSLPIMKQWAKVI
YDATHSVQLPGGLGDKSGGMREFIFPLIRAAVAVGCDGVFMETHPEPEKALSDASTQLPL
SQLEGIIEAILEIREVASKYYETIPVK

# Drug_Target_1_Reaction:
phosphoenolpyruvate + D-arabinose 5-phosphate + H2O = 2-dehydro-3-deoxy-D-octonate 8-phosphate + phosphate

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Phosphoenolpyruvate + D-arabinose 5-phosphate + H(2)O = 2-dehydro-3-deoxy-D-octonate 8-phosphate + phosphate

# Drug_Target_1_SwissProt_ID:
O66496

# Drug_Target_1_SwissProt_Name:
KDSA_AQUAE

# Drug_Target_1_Synonyms:
3-deoxy-D-manno-octulosonic acid 8- phosphate synthetase
EC 2.5.1.55
KDO 8-P synthase
KDO-8-phosphate synthetase
KDOPS
Phospho-2- dehydro-3-deoxyoctonate aldolase

# Drug_Target_1_Theoretical_pI:
6.68

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Not Available

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
AF120091

# Drug_Target_2_GenBank_ID_Protein:
4589058

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
gpmI

# Drug_Target_2_Gene_Sequence:
>1536 bp
ATGAGTAAAAAACCGGTTGCGCTCATCATTTTAGACGGATTTGCGCTGCGCGACGAAACG
TACGGCAATGCGGTCGCTCAGGCGAACAAACCGAACTTTGACCGCTATTGGAACGAATAC
CCGCACACAACGCTCAAGGCGTGCGGCGAGGCGGTCGGGCTTCCGGAAGGGCAGATGGGC
AACTCGGAAGTCGGCCATCTCAACATCGGCGCCGGGCGCATTGTGTACCAAAGCTTAACG
CGAATCAACATTGCCATTCGCGAAGGCGAGTTTGACCGAAATGAAACGTTTTTGGCGGCG
ATGAACCATGTGAAACAACACGGGACAAGTTTGCATTTGTTCGGCTTGCTTTCCGACGGC
GGGGTGCACAGCCATATTCACCATTTGTACGCCCTCTTGCGCTTGGCGGCGAAAGAAGGC
GTGAAGCGCGTGTACATCCACGGCTTTTTGGACGGCCGCGACGTCGGCCCACAAACAGCG
CCGCAATACATTAAAGAACTGCAGGAAAAAATCAAGGAATATGGCGTCGGCGAAATCGCG
ACGTTATCGGGCCGCTACTACTCGATGGACCGCGACAAGCGGTGGGACCGCGTCGAAAAG
GCGTATCGGGCGATGGTGTACGGGGAAGGGCCGACGTACCGCGATCCGCTCGAGTGCATC
GAGGACTCGTACAAACACGGCATTTACGACGAATTCGTCCTGCCGTCGGTCATCGTCCGC
GAAGACGGCCGGCCGGTGGCGACGATTCAAGACAATGACGCGATTATCTTCTATAATTTC
CGCCCTGACCGGGCGATCCAAATTTCAAACACGTTTACGAACGAAGATTTCCGCGAGTTT
GACCGCGGCCCGAAACATCCGAAGCATTTGTTCTTTGTCTGCTTGACCCATTTCAGCGAA
ACGGTGAAAGGGTACGTGGCGTTCAAGCCGACGAACTTGGACAACACGATCGGGGAAGTG
CTGTCGCAGCACGGACTGCGCCAGCTGCGCATCGCCGAGACCGAAAAATATCCGCACGTG
ACGTTTTTTATGAGCGGCGGCCGCGAAGAGAAATTTCCAGGCGAAGACCGGATTTTGATC
AACTCGCCGAAAGTGCCGACGTATGACTTGAAGCCGGAAATGAGCGCCTATGAAGTGACC
GATGCGCTGCTCAAGGAAATTGAAGCCGATAAGTACGATGCGATCATTTTGAACTACGCC
AACCCGGATATGGTCGGCCATTCGGGCAAGCTCGAACCGACGATCAAGGCGGTGGAGGCA
GTGGACGAATGCCTCGGCAAAGTCGTCGATGCCATTTTGGCCAAAGGCGGCATCGCCATC
ATCACCGCCGACCACGGCAACGCCGATGAAGTATTGACGCCGGACGGCAAGCCGCAAACG
GCTCATACGACGAATCCGGTGCCGGTCATCGTGACGAAAAAAGGCATCAAGCTTAGAGAC
GGCGGCATCTTAGGCGATTTGGCGCCGACGATGCTCGATTTGCTCGGCTTGCCGCAGCCG
AAAGAAATGACGGGGAAATCGTTGATTGTCAAATAA

# Drug_Target_2_General_Function:
Carbohydrate transport and metabolism

# Drug_Target_2_General_References:
10388626	Chander M, Setlow P, Lamani E, Jedrzejas MJ: Structural studies on a 2,3-diphosphoglycerate independent phosphoglycerate mutase from Bacillus stearothermophilus. J Struct Biol. 1999 Jun 15;126(2):156-65.
10747010	Jedrzejas MJ, Chander M, Setlow P, Krishnasamy G: Structure and mechanism of action of a novel phosphoglycerate mutase from Bacillus stearothermophilus. EMBO J. 2000 Apr 3;19(7):1419-31.
10764795	Jedrzejas MJ, Chander M, Setlow P, Krishnasamy G: Mechanism of catalysis of the cofactor-independent phosphoglycerate mutase from Bacillus stearothermophilus. Crystal structure of the complex with 2-phosphoglycerate. J Biol Chem. 2000 Jul 28;275(30):23146-53.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
2262

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
57004

# Drug_Target_2_Name:
2,3-bisphosphoglycerate-independent phosphoglycerate mutase

# Drug_Target_2_Number_of_Residues:
511

# Drug_Target_2_PDB_ID:
1O98

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF01676	Metalloenzyme
PF06415	iPGM_N

# Drug_Target_2_Protein_Sequence:
>2,3-bisphosphoglycerate-independent phosphoglycerate mutase
MSKKPVALIILDGFALRDETYGNAVAQANKPNFDRYWNEYPHTTLKACGEAVGLPEGQMG
NSEVGHLNIGAGRIVYQSLTRINIAIREGEFDRNETFLAAMNHVKQHGTSLHLFGLLSDG
GVHSHIHHLYALLRLAAKEGVKRVYIHGFLDGRDVGPQTAPQYIKELQEKIKEYGVGEIA
TLSGRYYSMDRDKRWDRVEKAYRAMVYGEGPTYRDPLECIEDSYKHGIYDEFVLPSVIVR
EDGRPVATIQDNDAIIFYNFRPDRAIQISNTFTNEDFREFDRGPKHPKHLFFVCLTHFSE
TVKGYVAFKPTNLDNTIGEVLSQHGLRQLRIAETEKYPHVTFFMSGGREEKFPGEDRILI
NSPKVPTYDLKPEMSAYEVTDALLKEIEADKYDAIILNYANPDMVGHSGKLEPTIKAVEA
VDECLGKVVDAILAKGGIAIITADHGNADEVLTPDGKPQTAHTTNPVPVIVTKKGIKLRD
GGILGDLAPTMLDLLGLPQPKEMTGKSLIVK

# Drug_Target_2_Reaction:
2-phospho-D-glycerate = 3-phospho-D-glycerate

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
Catalyzes the interconversion of 2-phosphoglycerate and 3-phosphoglycerate

# Drug_Target_2_SwissProt_ID:
Q9X519

# Drug_Target_2_SwissProt_Name:
GPMI_GEOSE

# Drug_Target_2_Synonyms:
BPG-independent PGAM
EC 5.4.2.1
Phosphoglyceromutase
iPGM

# Drug_Target_2_Theoretical_pI:
6.39

# Drug_Target_2_Transmembrane_Regions:
None

# Drug_Target_3_Cellular_Location:
Not Available

# Drug_Target_3_Chromosome_Location:
Not Available

# Drug_Target_3_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_3_Essentiality:
Non-Essential

# Drug_Target_3_GenAtlas_ID:
Not Available

# Drug_Target_3_GenBank_ID_Gene:
L01654

# Drug_Target_3_GenBank_ID_Protein:
160706

# Drug_Target_3_GeneCard_ID:
Not Available

# Drug_Target_3_Gene_Name:
TPI

# Drug_Target_3_Gene_Sequence:
>747 bp
ATGGCTAGAAAATATTTTGTCGCAGCAAACTGGAAATGTAATGGAACTTTAGAAAGTATT
AAATCTTTAACAAACAGTTTTAACAATTTGGATTTTGATCCAAGCAAATTAGACGTTGTT
GTTTTTCCTGTTTCCGTACATTATGATCATACAAGGAAATTACTTCAGAGTAAGTTTTCT
ACTGGTATTCAGAATGTATCAAAATTCGGAAATGGATCATACACAGGTGAAGTAAGTGCA
GAAATTGCCAAGGATTTAAATATTGAATATGTTATTATTGGTCATTTTGAAAGAAGAAAA
TATTTCCATGAAACCGATGAAGATGTTCGTGAAAAATTACAAGCTTCATTAAAAAATAAT
TTAAAAGCCGTTGTATGTTTTGGTGAATCTTTAGAACAAAGAGAACAAAATAAAACTATC
GAAGTTATTACAAAACAAGTTAAAGCATTTGTTGATTTAATTGATAATTTTGATAATGTT
ATTTTGGCTTATGAACCTTTATGGGCTATTGGTACTGGTAAAACAGCTACACCTGAACAA
GCTCAATTAGTACACAAAGAAATCAGAAAAATTGTAAAAGATACATGCGGAGAAAAACAA
GCTAACCAAATAAGAATATTATATGGAGGTAGTGTTAATACTGAAAACTGCTCTTCATTA
ATTCAACAAGAAGATATTGATGGTTTCTTAGTTGGAAATGCTTCCTTAAAAGAATCTTTT
GTTGATATAATAAAAAGTGCTATGTAA

# Drug_Target_3_General_Function:
Carbohydrate transport and metabolism

# Drug_Target_3_General_References:
7903426	Ranie J, Kumar VP, Balaram H: Cloning of the triosephosphate isomerase gene of Plasmodium falciparum and expression in Escherichia coli. Mol Biochem Parasitol. 1993 Oct;61(2):159-69.
9261072	Velanker SS, Ray SS, Gokhale RS, Suma S, Balaram H, Balaram P, Murthy MR: Triosephosphate isomerase from Plasmodium falciparum: the crystal structure provides insights into antimalarial drug design. Structure. 1997 Jun 15;5(6):751-61.

# Drug_Target_3_HGNC_ID:
Not Available

# Drug_Target_3_HPRD_ID:
Not Available

# Drug_Target_3_ID:
2314

# Drug_Target_3_Locus:
Not Available

# Drug_Target_3_Molecular_Weight:
27935

# Drug_Target_3_Name:
Triosephosphate isomerase

# Drug_Target_3_Number_of_Residues:
248

# Drug_Target_3_PDB_ID:
1O5X

# Drug_Target_3_Pathway:
Not Available

# Drug_Target_3_Pfam_Domain_Function:
PF00121	TIM

# Drug_Target_3_Protein_Sequence:
>Triosephosphate isomerase
MARKYFVAANWKCNGTLESIKSLTNSFNNLDFDPSKLDVVVFPVSVHYDHTRKLLQSKFS
TGIQNVSKFGNGSYTGEVSAEIAKDLNIEYVIIGHFERRKYFHETDEDVREKLQASLKNN
LKAVVCFGESLEQREQNKTIEVITKQVKAFVDLIDNFDNVILAYEPLWAIGTGKTATPEQ
AQLVHKEIRKIVKDTCGEKQANQIRILYGGSVNTENCSSLIQQEDIDGFLVGNASLKESF
VDIIKSAM

# Drug_Target_3_Reaction:
D-glyceraldehyde 3-phosphate = glycerone phosphate

# Drug_Target_3_Signals:
None

# Drug_Target_3_Specific_Function:
D-glyceraldehyde 3-phosphate = glycerone phosphate

# Drug_Target_3_SwissProt_ID:
Q07412

# Drug_Target_3_SwissProt_Name:
TPIS_PLAFA

# Drug_Target_3_Synonyms:
EC 5.3.1.1
TIM
Triose-phosphate isomerase

# Drug_Target_3_Theoretical_pI:
6.37

# Drug_Target_3_Transmembrane_Regions:
None

#END_DRUGCARD DB01709
